← Open Payments lookup

KAREN GARCIA: Open Payments

NPI 1205520608 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$752 in 34 payments from 14 companies in 2025. Trend: 2023 $17 · 2024 $1,068 · 2025 $752

Food & beverage: $752
CompanyPaymentsAmount
ABBVIE INC.12$193
E.R. Squibb & Sons, L.L.C.4$95
Lundbeck LLC4$94
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$83
Neurocrine BioSciences, Inc.2$65
Indivior Inc.1$38
Janssen Pharmaceuticals, Inc1$30
Vanda Pharmaceuticals Inc.1$28
Alkermes, Inc.1$27
Teva Pharmaceuticals USA, Inc.1$25

Products named: VRAYLAR, COBENFY, CAPLYTA, REXULTI, INGREZZA, ABILIFY ASIMTUFII, SUBLOCADE, INVEGA SUSTENNA.

Industry payments across MD — which companies pay providers there.